This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...